From ‘Syndrome X’ to the Thrifty Phenotype: A Reappraisal of the Insulin Resistance Theory of Atherogenesis

Ostrander LD Francis T Hayner NS Kjelsberg MO Epstein FH . The relation of cardiovascular disease to hyperglycaemia. Ann Intern Med 1965; 62: 1188–98.

Nikkila EA Miettinen TA Vesenne M-R Pelkonen R. Plasma insulin in coronary heart disease. Lancet 1965; ii: 508–11.

Peters N Hales CN . Plasma insulin concentrations after myocardial infarction. Lancet 1965; i: 1144–45.

Keen H Rose G Pyke DA Boyns D Chlouverakis C Mistry S. Blood sugar and arterial disease. Lancet 1965; ii: 505–8.

Welborn TA Breckenridge A Rubinstein AH Dollery CT Fraser TR . Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1966; i: 1336–37.

Stout RW Vallance-Owen J. Insulin and atheroma. Lancet 1969; i: 1078–80.

Reaven GM . Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.

Kaplan NM . Syndromes X: Two too many. Am J Cardiol 1992; 69: 1643–14.

Hollenbeck C Reaven GM . Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169–73.

Shen S-W Reaven GM Farquhar JW . Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970; 49: 2151–60.

Ginsberg H. Olefsky JM Reaven GM . Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes 1974; 23: 674.

DeFronzo RA . The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667–87.

Saad MF Pettit DJ Mott DM Knowler WC Nelson RG Bennet PH . Sequential changes in serum insulin concentration during development of non-insulin dependent diabetes. Lancet 1989; i: 1356–59.

Lillioja S Mott DM Howard BV Bennet PH Yki-Jarvinen H Freymond D Nyomba BL Zurlo F Swinburn S Bogardus C. Impaired glucose tolerance as a disorder of insulin action. N Engl J Med 1988; 318: 1216–25.

Caro JF . Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991; 73: 691–95.

Prager R Wallace P Olefsky JM . Hyper-insulinaemia does not compensate for peripheral insulin resistance in obesity. Diabetes 1987; 36: 327–34.

Swinburn B Nyomba BL Saad MF Zurlo F Raz I Knowler WC Lillioja S Bogardus C Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991; 88: 168–73.

Landsberg L. Diet, obesity and hypertension: An hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. QJ Med 1986; 236: 1081–90.

Himsworth HP . Diabetes mellitus. Its differentiation into insulin-sensitive and insulin-insensitive forms. Lancet 1936; i: 127–30.

DeFronzo RA Tobin JD Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–E223.

Harano Y Ohgaku S Hidaka H Haneda K Kikkawa R Shigeta Y Abe H. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab 1977; 45: 1124–27.

Heine RJ Home PD Poncher M Orskov H Hammond V McCulloch AJ Hanning I Alberti KGMM . A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance. Diabetes Res 1985; 2: 113–20.

Akinmokun A Selby PL Ramaiya K Alberti KGMM . The short insulin tolerance test for determination of insulin sensitivity: A comparison with the euglycaemic clamp. Diabetic Med 1992; 9: 423–37.

Bergmann RN Ider YZ Bowden CR Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236: E667–E677.

Matthews DR Hosier JP Rudenski JS Naylor BA Treacher DR Turner RC . Homeostasis model assessment; insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–19.

Rosetti L Giaccari A DeFronzo RA . Glucose toxicity. Diabetes Care 1990; 13: 610–29.

DeFronzo RA . Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: A balanced overview. Diabetologia 1992; 35: 389–97.

Bruce DG Chisholm DJ Storlien LH Kraegen EW . Physiological importance of deficiency in early postprandial insulin secretion in non-insulin dependent diabetes. Diabetes 1988; 37: 736–44.

Mitrakou A Kelley D Mokan M Veneman T Pangburn T Reilly J Gerich J. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992; 326: 22–29.

Pouliot M-C Despres J-P Nadeau A Moorjani S Prud-Homme D Lupien PJ Tremblay A Bouchard C. Visceral obesity in man. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41: 826–34.

Williams DRR Byrne C Clark PMS Cox L Day NE Palmer CR Wang T Hales CN . Insulin deficiency in early type 2 diabetes — evidence from the Ely Diabetes Project. Diabetic Med 1992; 9 (suppl 2): S15, A17.

Ferrannini E Buzzigoli G Bonadonna R Giorico MA Oleggini M Graziadei L Pedrinelli R Brandi L Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–57.

Manicardi V Camellini L Bellodi G Coscelli C Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinaemia in obese man. J Clin Endocrinol Metab 1986; 62: 1302–304.

Rizza RA Mandarino LJ Genest J Baker BA Gerich JE . Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 1985; 28: 70–75.

Peiris AN Stagner JI Vogel RL Nakagawa A Samols E. Body fat distribution and peripheral insulin sensitivity in healthy men: Role of insulin pulsatility. J Clin Endocrinol Metab 1992; 75: 290–93.

Temple RC Clark P Schneider A Nagi DK Hendra TJ Yudkin JS Hales CN . Radioimmunoassay may overestimate insulin in non-insulin dependent diabetics. Clin Endocrinol 1990; 32: 689–93.

Florey C du V Uppal S Lowy C. Relation between blood pressure, weight, and plasma sugar and serum insulin levels in schoolchildren aged 9–12 years in Westland, Holland. Br Med J 1976; 1: 1368–71.

Burke GL Webber LS Srinivasan SR Radhakrishnamurthy B Freedman DS Berenson GS . Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism 1986; 35: 441–46.

King H Alpers M Finch C Zimmet P. Future glucose intolerance possibly manifest in youth. Lancet 1989; ii: 1098–99.

Pettit DJ Moll PP Kottke BA . Insulin resistance in apparently healthy children. Diabetes 1990; 39: 75A.

Zavaroni I Bonora E Pagliara M Dall'Aglio E Luchetti L Buonanno G Bonati PA Bergonzani M Gnudi L Passeri M Reaven G. Risk factors for coronary artery disease in healthy persons with hyperinsulinaemia and normal glucose tolerance. N Engl J Med 1989; 320: 702–706.

Zavaroni I Mazza S Dall'Aglio E Gasperini P Passeri M Reaven GM . Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med 1992; 231: 235–40.

Foster DW . Insulin resistance — a secret killer? N Engl J Med 1989; 320: 733–34.

Williams RR Hunt SC Hopkins PN Stults BM Wu LL Hasstedt SJ Barlow GK Stephenson SH Lalouel J-M Kuida H. Familial dyslipidaemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988; 259: 3579–86.

Haffner SM Valdez RA Hazuda HP Mitchell BD Morales PA Stern MP . Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992; 41: 715–22.

Fontbonne A Charles MA Thibult N Richard J-L Claude J-R Warnet J-M Rosselin GE Eschwege E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study, 15 year follow up. Diabetologia 1991; 34: 356–61.

Cambien F Warnet J-M Eschwege E Richard J-L Rosselin G. Body mass, blood pressure, glucose and lipids. Does plasma insulin explain their relationship? Arteriosclerosis 1987; 7: 197–202.

Fontbonne A Eschwege E Cambien F Richard J-L Ducimetiere P Thibult N Warnet J-M. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 1989; 32: 300–304.

Fontbonne A Thibult N Eschwege E Ducimetiere P. Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: The Paris Prospective Study, 15 year follow-up. Diabetologia 1992; 35: 464–68.

Golay A Chen Y-DI Reaven GM . Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab 1986; 62: 1081–88.

Lillioja S Mott DM Zawadski JK Young AA Abbott WG Bogardus C. Glucose storage is a major determinant of in vivo insulin resistance in subjects with normal glucose tolerance. J Clin Endocrinol Metab 1986; 62: 922–27.

Kolterman OG Insel J Saekow M Olefsky JM . Mechanisms of insulin resistance in human obesity. J Clin Invest 1980; 65: 1272–84.

Bjorntorp P. ‘Portal’ adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10: 493–96.

Ferrannini E Barret EJ Bevilacqua S DeFronzo RA . Effect of fatty acids on glucose production and utilisation in man. J Clin Invest 1983; 72: 1737–47.

Bevilacqua S Bonadonna R Buzzigoli G Boni C Cociaro D Maccari F Giorico MA Ferrannini E. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 1987; 36: 502–506.

Golay A Swislocki ALM Chen Y-DI Reaven GM . Relationships between plasma free fatty acid concentration, endogenous glucose production, and fasting hyperglycaemia in normal and non-insulin dependent diabetic individuals. Metabolism 1987; 36: 692–96.

Randle PJ Garland PB Hales CN Newsholme EA . The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785–89.

Kissebah AH Vydelingum N Murray R Evans DJ Hartz AJ Kalkhoff RK Adams PW . Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254–60.

McKeigue PM Pierpoint T Ferrie JE Marmot MG . Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans. Diabetologia 1992; 35: 785–811.

Hubert HB Feinleib M McNamara PM Castelli WP . Obesity as an independent risk factor for cardiovascular disease: A 26 year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–77.

McMahon SW MacDonald GJ Bernstein L Andrews G Blackett RB . Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet 1985; i: 1233–36.

Tuck ML Sowers J Dornfeld L Kledzik G Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930–33.

Henry RR Wallace P Olefsky JM . Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin dependent diabetes mellitus. Diabetes 1986; 35: 990–98.

Krotkiewski M Mandroukas K Sjostrom L Sullivan L Wetterqvist H Bjorntorp P. Effects of long term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 1979; 28: 650–58.

Horton ES . Exercise and physical training: Effect on insulin sensitivity and glucose metabolism. Diabetes Metab Rev 1986; 2: 1–17.

Van Gaal L Rillaerts E Creten W De Leeuw I. Relationship of body fat distribution pattern to atherogenic risk factors in NIDDM. Diabetes Care 1988; 11: 103–106.

Larsson B Svarstudd K Welin L Wilhelmsen L Bjorntorp P Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401–404.

Lapidus L Bengtsson C Larsson B Pennert K Rybo E Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 289: 1257–61.

Stern M Haffner SM . Body fat distribution and hyperinsulinaemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 1986; 6: 123–30.

Knight TM Smith Z Whittles A Sahota P Lockton JA Hogg G Bedford A Toop M Kernohan EEM Baker MR . Insulin resistance, diabetes, and risk markers for ischaemic heart disease in Asian men and non-Asian men in Bradford. Br Med J 1992; 67: 343–50.

Seidell JC Cigolini M Charzewska J Ellsinger B-M DiBiase G Bjorntorp P Hautvast JGAJ Contaldo F Szostak V Scuro LA . Indicators of fat distribution, serum lipids, and blood pressure in European women born in 1948 — The European Fat Distribution Study. Am J Epidemiol 1989; 130: 53–65.

Peiris AN Mueller RA Smith GA Struve MF Kissebah AH . Splanchnic insulin metabolism in obesity. J Clin Invest 1986; 78: 1648–57.

Walton C Godsland IF Proudler AJ Felton CV Wynn V. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in non-obese healthy men. J Clin Endocrinol Metab 1992; 75: 170–75.

Kanai H Matsuzawa Y Kotani K . Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension 1990; 16: 484–90.

Fujioka S Matsuzawa Y Tokunaga K Tarui S. Contribution of intraabdominal fat accumulation in the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54–59.

Despres J-P Nadeau A Tremblay A Ferland M Moorjani S Lupien PJ Theriault G Pinault S Bouchard C. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in women. Diabetes 1989; 38: 304–309.

Despres JP Moorjani S Ferland M Tremblay A Lupien PJ Nadeau A Pinault S Theriault G Bouchard C. Adipose tissue distribution and plasma lipoprotein levels in obese women: Importance of intraabdominal fat. Arteriosclerosis 1989; 9: 203–10.

Peiris AN Sothmann MS Hoffmann RG Hennes MI Wilson CR Gustafson AB Kissebah AH . Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 1989; 110: 867–72.

Peiris AN Sothmann MS Hennes MI Lee MB Wilson CR Gustafson AB Kissebah AH . Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: Predictive values of selected indices in premenopausal women. Am J Clin Nutr 1989; 49: 758–64.

Seidell JC Bjorntorp P Sjostrom L Kvist H Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39: 897–901.

Berglund G Larson B Andersson O . Body composition and glucose metabolism in hypertensive middle aged males. Acta Med Scand 1976; 200: 163–69.

Modan M Halkin H Almog S Lusky A Eshkol A Sheki M Shitrit A Fuchs Z. Hyperinsulinaemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809–17.

Asch S Wingard DL Barret-Connor EL . Are insulin and hypertension independently related? Ann Epidemiol 1991; 1: 231–44.

Shen D-C Shieh S-M Fuh MM-T Wu D-A Chen Y-DI Reaven GM . Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66: 580–83.

Gans ROB Bilo HJG Nauta JJP Heine RJ Donker AJM . Acute hyperinsulinaemia induces sodium retention and a blood pressure decline in diabetes mellitus. Hypertension 1992; 20: 199–209.

Mbanya J-CN Wilkinson R Thomas TH Alberti KGMM Taylor R. Hypertension and hyperinsulinaemia: A relation in diabetes but not essential hypertension. Lancet 1988; i: 733–34.

Salvatore T Cozzolino D Giunta R Giugliano D Torella R D'Onofrio F. Decreased insulin clearance as a feature of essential hypertension. J Clin Endocrinol Metab 1992; 74: 144–49.

Fujita N Baba T Tomiyama T Kodama T Kako N. Hyperinsulinaemia and blood pressure in patients with insulinoma. Br Med J 1992; 304: 1157.

Pontiroli AE Alberetto M Pozza G. Patients with insulinoma show insulin resistance in the absence of arterial hypertension. Diabetologia 1992; 35: 294–95.

Hall JE Brands MW Kivlighn SD Mizelle HL Hilderbrandt DA Gaillard CA . Chronic hyperinsulinaemia and blood pressure. Interaction with catecholamines. Hypertension 1990; 15: 519–27.

Laakso M Edelman SV Brechtel G Baron A. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992; 41: 1076–83.

DeFronzo RA . The effect of insulin on renal sodium metabolism. Diabetologia 1981; 21: 165–71.

Kornel L Prancan AV . Insulin inhibits conversion of Cortisol to C19-metabolites in mineralocorticoid responsive tissues. J Hypertens 1992; 10 (suppl 4): S27.

Skott P Vaag A Bruun NE Hother-Nielsen O Gall MA Beck-Nielsen H Parving H-H. Normal sodium retaining effect of insulin in type 2 (non insulin dependent) diabetes mellitus — a state of peripheral insulin resistance and hyperinsulinaemia. Diabetologia 1990; 33: A21.

Conover CA Lee PDK Kanaley JA Clarkson JT Jensen MD . Insulin regulation of insulin-like growth factor binding protein-1 in obese and non-obese human subjects. J Clin Endocrinol Metab 1992; 74: 1355–60.

Batch JA Baxter RC Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991; 73: 964–68.

Bar RS Boes M Clemmons DR Busby WH Sandra A Dake BL Booth BA . Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology 1990; 127: 497–99.

Rowe JW Young JB Minaker KL Stevens AL Pallota J Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30: 219–25.

O'Hare JA Minaker K Young JB Rowe JW Pallota JA Landsberg L. Insulin increases plasma norepinephrine (NE) and lowers plasma potassium equally in lean and obese men. Clin Res 1985; 33: 441A.

Stout RW Bierman EL Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975; 36: 319–27.

King GL Goodman AD Buzney S Moses A Kahn CR . Receptors and growth promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985; 75: 1028–36.

Klip A Ramlal T Cragoe EJ . Insulin-induced cytoplasmic alkalinisation and glucose transport in muscle cells. Am J Physiol 1986; 250: C720–C728.

Bunker CH Wing RR Mallinger AG Becker DJ Matthews KA Kuller LH . Cross-sectional and longitudinal relationship of sodium-lithium countertransport to insulin, obesity, and blood pressure in healthy perimenopausal women. J Hum Hypertens 1991; 5: 381–92.

Foyle W-J Drury PL . Reduction of Li⁺-Na⁺ countertransport by physiological levels of insulin in vitro. J Hypertens 1991; 9: 713–17.

Doria A Fioretto P Avogaro A Carraro A Morocutti A Trevisan R Frigato F Crepaldi G Viberti G-C Nosadini R. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 1991; 261: E684–E691.

Skott P Hother-Nielsen O Bruun NE Giese J Nielsen MD Beck-Nielsen H Parving H-H. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989; 32: 694–99.

Gans ROB Donker AJM . Insulin and blood pressure regulation. J Intern Med 1991; 229 (suppl 2): 49–64.

Solt VB Brown MR Kennedy B Kolterman OG Ziegler MG . Elevated insulin, norepinephrine, and neuropeptide-Y in hypertension. Am J Hypertens 1990; 3: 823–28.

Landsberg L. The sympathetic nervous system in obesity-related hypertension. Medicographia 1991; 13: 27–30.

Carstensen E Mohamed-Ali V Yudkin JY . Is sympathoadrenomedullary activity increased in hyperinsulinaemia subjects? Diabetic Med 1992; 9 (suppl 2): S28, A23.

Anderson KM Castelli WP Levy D. Cholesterol and mortality. 30 years of follow up from the Framingham Study. JAMA 1987; 257: 2176–80.

Kannel WB McGee DL . Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 1979; 59: 8–13.

Miller GJ Miller NE . Plasma high-density lipoprotein concentration and development of ischaemic heart disease. Lancet 1975; i: 16–18.

Castelli WP . The triglyceride issue: A view from Framingham. Am Heart J 1986; 112: 432–37.

Aberg H Lithell H Selinus I Hedstrand H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10 year follow up of Uppsala Primary Preventive Study. Atherosclerosis 1985; 54: 89–97.

Tzagournis M Chiles R Ryan JM Skillman TG . Interrelationships of hyperinsulinaemia and hypertriglyceridaemia in young patients with coronary heart disease. Circulation 1968; 38: 1156–63.

Orchard TJ Becker DJ Bates M Kuller LH Drash AL . Plasma insulin and lipoprotein concentrations: An atherogenic association? Am J Epidemiol 1983; 118: 326–37.

Laakso M Pyorala K Voutilainen E Marniemi J. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin dependent and non-diabetic subjects. Am J Epidemiol 1987; 125: 611–21.

Olefsky JM Farquhar JW Reaven GM . Reappraisal of the role of insulin in hypertriglyceridaemia. Am J Med 1974; 57: 551–59.

Greenfield M Kolterman O Olefsky J Reaven GM . Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia 1980; 18: 441–46.

Chen Y-DI Golay A Swislocki ALM Reaven GM . Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1987; 64: 17–21.

Patsch W Franz S Schonfeld G. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest 1983; 71: 1161–74.

Taskinen M-R. Hyperlipidaemia in diabetes. Clin Endocrinol Metab 1990; vmr-4: 743–50.

Chait A Bierman EL Albers JJ . Low density lipoprotein receptor activity in cultured human skin fibroblasts. J Clin Invest 1979; 64: 1309–19.

Hiramatsu K Bierman E Chait A. Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridaemia by cultured human skin fibroblasts. Diabetes 1985; 34: 8–14.

Shen MMS Krauss RM Lindgren FT Forte TM . Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 1981; 22: 236–44.

Crouse JR Parks JS Schey HM Kahl FR . Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 1985; 26: 566–74.

Barakat HA Carpenter JW McLendon VD Khazanie P Leggett N Heath J Marks R. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Diabetes 1990; 39: 1527–33.

James RW Pometta D. The distribution profiles of very low density and low density lipoproteins in poorly controlled male, type 2 non-insulin dependent diabetic patients. Diabetologia 1991; 34: 246–52.

Peebles Harris L Carpenter JW Israel RG Barakat HA . Alterations in low density lipoprotein in subjects with abdominal adiposity. Metabolism 1989; 38: 1029–36.

Terry RB Wood PD Haskell WL Stefanick ML Krauss RM . Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. J Clin Endocrinol Metab 1989; 68: 191–99.

Fearnley GR Chakrabarti R Avis PRD . Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity. Br Med J 1963; 1: 921–23.

Shaw DA MacNaughton D. Relationship between blood fibrinolytic activity and body fatness. Lancet 1965; i: 352–54.

Andersen P Arnesen H Hjermann I. Hyperlipoproteinaemia and reduced fibrinolytic activity in healthy coronary high-risk men. Acta Med Scand 1981; 209: 199–202.

Hamsten A Walldius G Szamosi A Blomback M de Faire U Dahlen G Landou C Wimen B. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987; ii: 3–9.

Alessi MC Juhan-Vague I Kooistra T Declerck PJ Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line HepG2. Thromb Haemost 1988; 60: 491–94.

Schneider DJ Nordt TK Sobel BE . Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 1992; 41: 890–95.

Kooistra T Bosma PJ Tons HAM Van den Berg AP Meyer P Princen HMG . Plasminogen activator inhibitor-1: Biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost 1989; 62: 723–28.

Landin K Stigendal L Eriksson E Krotkiewski M Risberg B Tengborn L Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044–48.

Juhan-Vague I Roul C Alessi MC Ardissone JP Heim M Vague P. Increased plasminogen activator inhibitor activity in non-insulin dependent diabetic patients-relationship with plasma insulin. Thromb Haemost 1989; 61: 370–73.

Nagi DK Hendra TJ Ryle AJ Cooper TM Temple RC Clark PMS Schneider AE Hales CN Yudkin JS . The relationship of concentrations of insulin, intact proinsulin and 32–33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin dependent) diabetic subjects. Diabetologia 1990; 33: 532–37.

Landin K Tengborn L Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 1990; 227: 273–78.

Stiko-Rahm A Wiman B Hamsten A Nilsson J. Secretion of plasminogen activator inhibitor 1 from cultured human umbilical vein cells is induced by very low density lipoprotein. Arteriosclerosis 1990; 10: 1067–73.

Grant PJ Kruithof EKO Felley CP Felber JP Bachmann F. Short term insulin infusion of insulin, triacylglycerol and glucose do not cause acute increase in plasminogen activator inhibitor 1 concentration in man. Clin Sci 1990; 79: 513–16.

Jain SK Nagi DK Slavin BM Lumb PJ Yudkin JS . Insulin therapy in type 2 diabetic subjects suppressed plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control. Diabetic Med 1992; 9: 1–6.

van Loon Potter BJ Kluft C Radder JK Blankenstein MA Meinders AE . Plasminogen activator inhibitor 1 levels in plasma are associated with insulin resistance. Diabetologia 1992; 35 (suppl 1): 26, A9.

Juhan-Vague I Alessi MC Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457–62.

Gris JC Schved JF Aguilar-Martinez P Arnaud A Sanchez N. Impact of physical training on plasminogen activator inhibitor activity in sedentary men. Fibrinolysis 1990; vmr-4: 97–98.

Nilsson TK Sundell IB Hellsten G Hallman G. Reduced plasminogen activator inhibitor activity in high consumers of fruits, vegetables and root vegetables. J Intern Med 1990; 227: 267–71.

Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care 1979; 2: 131–41.

Ducimetiere P Eschwege E Papoz L Richard J-L Claude CR Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19: 205–10.

Welborn TA Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154–60.

Lichtenstein MJ Yarnell JWG Elwood PC Beswick AD Sweetnam PM Marks V Teale D Riad-Fahmy D. Sex hormones, insulin, lipids, and prevalent ischaemic heart disease. Am J Epidemiol 1987; 126: 647–57.

Bergstrand R Wiklund O Holm G Wedel H. Glucose tolerance, plasma insulin and alpha-lipoproteins in young male myocardial infarction survivors compared with controls matched on serum cholesterol concentration. Eur J Clin Invest 1979; 9: 381–84.

Mookherjee S Potts JL Hill NE Warner R Raheja KL Patel DG Vardan S Smulyan H. Lack of relationship between plasma insulin and glucagon levels and angiographically-documented coronary atherosclerosis. Atherosclerosis 1984; 53: 99–109.

Uusitupa M Siitonen O Pyorala K Aro A Hersio K Penttila I Voutilainen E. The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin dependent) diabetes. Diabetologia 1985; 28: 653–59.

Ronemaa T Laakso M Puukka P Kallio V Pyorala K. Atherosclerotic vascular disease in middle aged insulin treated diabetic patients: Associations with endogenous insulin secretion capacity. Arteriosclerosis 1988; 8: 237–44.

Standi E Janka HU . High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease in type 2 diabetes. Horm Metab Res 1985; 15 (suppl): 46–51.

Hilson RM Hockaday TDR Mann JI Newton DJ . Hyperinsulinaemia is associated with development of electrocardiographic abnormalities in diabetics. Diabetes Res 1984; 1: 143–49.

Bergstrom RW Leonetti DL Newell-Morris LL Shuman WP Wahl PW Fujimoto WY . Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance. Diabetologia 1990; 33: 489–96.

Stout RW . Development of vascular lesions in insulin-treated animals fed on a normal diet. Br Med J 1970; 3: 685–87.

Cruz AB Amatuzio DS Grande F Hay LJ . Effect of intraarterial insulin on tissue cholesterol and fatty acids in alloxan treated diabetic dogs. Circ Res 1961; 9: 39–43.

Sato Y Shiraishi S Oshida Y Ishiguro T Sakamoto N. Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats. Diabetes 1989; 38: 91–96.

Stout RW . Insulin and atheroma. 20 year perspective. Diabetes Care 1990; 13: 631–55.

Steiner DF Oyer P. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci 1967; 57: 473–80.

Duckworth WC Kitabchi AE Heinemann M. Direct measurement of plasma proinsulin in normal and diabetic subjects. Am J Med 1972; 53: 418–27.

Howey DC Frank BH Galloway JA Root MA Spradlin CT . Human proinsulin (rDNA) as an intermediate-acting insulin agonist: A comparison with NPH (N) and regular (R) insulins. Diabetes 1984; 33 (suppl 1): 23A.

Galloway JA Hooper SA Spradlin CT Howey DC Frank BH Bowsher RR Anderson JH . Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies and clinical trial experience. Diabetes Care 1992; 15: 666–92.

Temple RC Clark P Schneider A Nagi DK Hendra TJ Yudkin JS Hales CN . Radioimmunoassay may overestimate insulin in non-insulin dependent diabetics. Clin Endocrinol 1990; 32: 689–93.

Sobey WJ Beer SF Carrington CA Clark PMS Frank BH Gray IP Luzio SD Owens DR Schneider AE Siddle K Temple RC Hales CN . Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 1989; 260: 535–41.

Mako ME Starr JI Rubinstein AH . Circulating proinsulin in patients with maturity onset diabetes. Am J Med 1977; 63: 865–869.

Ward WK LaCava EC Paquette TL Beard JC Wallum BJ Porte D. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987; 30: 698–702.

Yoshioka N Kazuya T Matsuda A Iwamoto Y. Effects of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDM. Diabetes 1989; 38: 262–67.

Revers RR Henry R Schmeiser L Kolterman O Cohen R Bergenstal R Polonsky K Jaspan J Rubinstein A Frank B Galloway J Olefsky JM . The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 1984; 33: 762–70.

Winocour PH Mallik TH Ishola M Baker RD Bhatnagar D Durrington PN Anderson DC . A randomised cross-over study of the effects of proinsulin on lipid metabolism in type 2 diabetes. Diabetic Med 1991; 8: 22–27.

Peavy DE Brunner MR Duckworth WC Hooker CS Frank BH . Receptor binding and biological potency of several forms (conversion intermediates) of human proinsulin. J Biol Chem 1985; 260: 13989–94.

Neel JV . Diabetes mellitus: A thrifty genotype rendered detrimental by ‘progress’? Am J Hum Genet 1962; 14: 353–62.

Moller DE Flier JS . Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938–43.

Eriksson J Koranyi L Bourey R Schalin-Jantti C Widen E Mueckler M Permutt MA Groop LC . Insulin resistance in type 2 (non-insulin dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT 4) gene in human skeletal muscle. Diabetologia 1992; 35: 143–47.

Borbaek C Vestergaard H Heding LG Cohen P Pedersen O. Analysis of genes encoding 3 key proteins in insulin resistant glucose utilisation of skeletal muscle from type 2 diabetics. Diabetologia 1992; 35 (suppl 1): A274.

Baroni MG Alcolado JC Galton JC Andreani D Pozzilli P. Sib pair analysis of the GLUT 1 glucose transporter gene in type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1992; 35 (suppl 1): A275.

Chiu KC Province MA Dowse GK Zimmet PZ Wagner G Serjeantson S Permutt MA . A genetic marker at the glucokinase gene locus for type 2 (non-insulin dependent) diabetes mellitus in Mauritian Creoles. Diabetologia 1992; 35: 632–38.

Hattersley AT Patel P Lo Y-MD Page R Cook JTE Salter PJ Tanizawa Y Chiu KC Watkins P Turner RC Permutt MA Wainscoat JC . Type 2 (non-insulin dependent) diabetes is linked to the glucokinase gene. Diabetologia 1992; 35 (suppl 1): A235.

Vionnet N Stoffel M Takeda J Zouali H Lasage S Froguel P Bell GI . Mutations in glucokinase gene cause early onset type 2 diabetes. Diabetologia 1992; 35 (suppl 1): A234.

Page RCL Hattersley AT Barrow B Patel P Wainscoat JS Permutt MA Turner RC . Clinical characteristics of type 2 diabetes linked to glucokinase gene. Diabetologia 1992; 35 (suppl 1): A236.

Vaxillaire M Butel MO Zouali H Sun F Lesage S Clement K Velho G Passa P Cohen D Froguel P. Linkage studies give evidence for genetic heterogeneity in type 2 diabetes mellitus. Diabetologia 1992; 35 (suppl 1): A237.

Forguel P Vionnet N Stoffel M Velho G Passa P Bell GI Cohen D. Different phenotypic expression by 3 mutant alleles of glucokinase gene in MODY. Diabetologia 1992; 35 (suppl 1): A238.

O'Rahilly SO Krook A Morgan R Rees A Flier JS Moller DE . Insulin receptor and insulin-responsive glucose transporter (GLUT 4) mutations and polymorphisms in a Welsh type 2 (non-insulin dependent) diabetic population. Diabetologia 1992; 35: 486–89.

Hales CN Barker DJP . Type 2 (non-insulin dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 1992; 35: 595–601.

Law CM Barker DJP Osmond C Fall CHD Simmonds SJ . Early growth and abdominal fatness in adult life. In: Barker DJP Robinson RJ eds. Fetal and infant origins of adult disease. London: British Medical Journal, 1992.

Lithell H Lindgarde F Hellsing K Lundqvist G Nygaard E Vessby B Saltin B. Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year old men. Diabetes 1981; 30: 19–25.

Lillioja S Young AA Culter CL Ivy JL Abbott WGH Zawadski JK Yki-Jarvinen H Christin L Secomb TW Bogardus C. Skeletal muscle capillary density and fibre type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987; 80: 415–24.

Wade AJ Marbut MM Round JM . Muscle fibre type and aetiology of obesity. Lancet 1990; 335: 805–808.

Gould MM Mohamed-Ali V Goubet SA Yudkin JS Haines AP . Microalbuminuria, height and sex differences in non-diabetic subjects. Br Med J 1992; 306: 240–42.

Dowse GK Zimmet P Finch CF Collins VR . Decline in incidence of epidemic glucose intolerance in Nauruans: Implications for the ‘thrifty genotype’ Am J Epidemiol 1991; 133: 1093–103.

O'Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle. Diabetes 1984; 33: 596–603.

Bjorntorp P de Jounge K Sjostrom L Sullivan L. The effect of physical training on insulin production in obesity. Metabolism 1970; 19: 631–38.

Dowse GK Zimmet PZ Gareeboo H Alberti KGMM Tuomilehto J Finch CF Chitson P Tulsidas H. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991; 14: 271–82.

Ravussin E Valencia ME Schulz LO Esparza J Bennet PH . Effect of a traditional lifestyle on the physical and metabolic characteristics of Pima Indians living in Northern Mexico. Diabetes 1992; 41: 1A.

Facchini FS Hollenbeck CB Jeppesen J Chen Y-DI Reaven GM . Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128–30.

Berne C Pollare T Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care 1991; 14 (suppl 4): 39–47.

Collins R Peto R MacMahon S . Blood pressure, stroke, and coronary heart disease. Part 2. Short term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38.

Yudkin JS . Hypertension and non-insulin dependent diabetes. Chicken, egg, tablets, or insulin resistance? Br Med J 1991; 303: 730–33.

Dahloff B Pennert K Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95–110.

Casale PN Devereux RB Milner M Zullo G Harshfield GA Pickering TG Laragh JH . Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173–78.